RHUMBLINE ADVISERS

Position in FTRE — Fortrea Holdings Inc.

CIK 1115418 BOSTON, MA

Position in FTRE

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,236,948

-$1,775,246 QoQ

Shares Held

237,468

+2.1% QoQ

Ownership

0.251%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 53.83083194367241.ToString("F0")% Shared 0.ToString("F0")% None 46.16916805632759.ToString("F0")%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,828,718 across 284 Biotechnology names. FTRE ranks #78 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	423,140	$188,948,935
2	REGN	Regeneron Pharmaceuticals, Inc.	157,781	$121,907,911
3	INCY	Incyte Corp	693,665	$65,287,749
4	ALNY	Alnylam Pharmaceuticals, Inc.	195,277	$64,611,300
5	INSM	INSMED Inc	272,615	$44,578,004
6	JAZZ	Jazz Pharmaceuticals plc	164,542	$31,106,665
7	EXEL	Exelixis, Inc.	723,931	$31,049,400
8	ROIV	Roivant Sciences Ltd.	1,113,266	$30,837,468

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,236,948	237,468	+2.1%	Shares	Sole	2026-05-12
2025-12-31	$4,012,194	232,591	-20.7%	Shares	Sole	2026-02-13
2025-09-30	$2,470,251	293,379	-2.9%	Shares	Sole	2025-11-06
2025-06-30	$1,491,993	302,023	+28.2%	Shares	Sole	2025-08-12
2025-03-31	$1,779,165	235,651	+0.5%	Shares	Sole	2025-05-29
2024-12-31	$4,374,152	234,539	+1.8%	Shares	Sole	2025-05-29
2024-09-30	$4,609,500	230,475	-0.1%	Shares	Sole	2024-11-12
2024-06-30	$5,386,942	230,803	-3.2%	Shares	Sole	2024-08-01
2024-03-31	$9,571,222	238,446	-5.5%	Shares	Sole	2024-05-09
2023-12-31	$8,806,700	252,341	+0.2%	Shares	Sole	2024-02-08
2023-09-30	$7,196,560	251,716	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.